Radiotekhnika Publishing House

2015

Insulin-like growth factors and serum igf binding proteins in ovarian tumor patients Вопросы биологической, медицинской и фармацевтической химии, No. 6, 2015 pp. 49-53

2014

Vegf signaling pathway components and matrix metalloproteinases - in tumors of patients with ovarian neoplasms Вопросы биологической, медицинской и фармацевтической химии, No. 8, 2014 pp. 47-52
Clinical significance of vegf and upa evaluation in breast cancer Вопросы биологической, медицинской и фармацевтической химии, No. 8, 2014 pp. 38-45

2013

Inculin-like growth factors in breast cancer patients - serum Вопросы биологической, медицинской и фармацевтической химии, No. 9, 2013 pp. 68-71
System of insulin-like growth factors in patients with cin and invasive cervical cancer Technologies of Living Systems, No. 4, 2013 pp. 47-52

2012

Comparative Analysis of Matrix Metalloproteinase-2 in Blood Serum and Tumors 64 of Patients with Malignant, Borderline and Benign Ovarian Neoplasms Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 36-40
Vascular Endothelial Growth Factor and its Type 1 and 2 Receptors in Ovarian Tumor Patients - Serum Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 30-35
Research of Epidermal Growth Factor Receptor and its Ligands in Ovarian Tumors Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 26-29
Serum Insulin-Like Growth Factors 1 and 2 and Insulin-Like Growth Factors Binding Proteins 1 and 3 in CIN and Invasive Cervical Cancer as Perspective Markers of Disease Progression Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 21-25
Inculin-like Growth Factors in Breast Cancer Patients - Serum Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2012 pp. 16-20
Clinic and morphological parallels of early breast cancer in the international cooperation Technologies of Living Systems, No. 3, 2012 pp. 57-64
The expression of MMP-2 and MMP-9 in CIN and microinvasive cervical cancer as markers of progression and invasion Technologies of Living Systems, No. 3, 2012 pp. 32-37

2011

Epidermal Growth Factor Receptor and its Ligands Content in Ovarian Tumors Technologies of Living Systems, No. 7, 2011 pp. 59-66
Matrix Metalloproteinases in Ovarian Cancer Patients Technologies of Living Systems, No. 7, 2011 pp. 50-58матриксная мета
Clinical Prospects of Matrix Metalloproteinases and Their Tissue Inhibitors Study in Ovarian Cancer Patients Вопросы биологической, медицинской и фармацевтической химии, No. 10, 2011 pp. 27-36